Similar Items: Use of Wearable Technology for Measuring and Characterizing Sedentary Behavior in People With Mild Cognitive Impairment and Dementia: Systematic Review
- Refining cognitive dispersion metrics for brain–behavior prediction in aging and mild cognitive impairment
- Currently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment
- Vascular cognitive impairment and dementia drug‐development pipeline 2025
- A potential multimodal biomarker – cognitive signature associated with the conversion from subjective cognitive decline to mild cognitive impairment
- Regional amyloid PET asymmetry and long‐term clinical trajectory in mild cognitive impairment
- A combination of ketones and NAD+ precursor preserves white matter integrity in mild cognitive impairment